Current pre-clinical exploring the combination of radiotherapy with PD-1/PD-L1 inhibitors, as well as CAR-T cell therapy, to assess their synergistic potential in overcoming immune evasion and improving treatment outcomes in osteosarcoma patients are pending. This evidence concerns the gene CD274 and osteosarcoma.